loader
Please Wait
Applying Filters...
menu
    • menu

    Company Digital Content of Ethypharm

    Ethypharm-PSE
    News
    Acquisition Of Argatroban Business In Europe

    17 Jun 2024

    // PRESS RELEASE

    Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China

    13 Jun 2024

    // PRESS RELEASE

    Ethypharm ready to bring to patients world-leading digital therapies

    06 Apr 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Ethypharm

    Contact Supplier

    Website

    CPhI Worldwide, Milan

    Booth #7G84

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    Menu

    Ethypharm

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/ethypharm-party-content-97467.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/ethypharm-party-content-79941.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2022

    read-more

      https://www.pharmacompass.com/pdf/party/content/ethypharm-party-content-79362.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Pharmaceutical Capabilities

    read-more

      https://www.pharmacompass.com/pdf/party/content/ethypharm-party-content-84782.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Acquisition Of Argatroban Business In Europe
    Acquisition Of Argatroban Business In Europe

    17 Jun 2024

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2024/06/18-06-24-Press-Release-Argatroban-Ethypharm-Final.pdf

    PRESS RELEASE
    17 Jun 2024
    Share Share
    Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China
    Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China

    13 Jun 2024

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2024/06/13062024_Group-PR_-Ethypharm-Expands-its-Mesalazine-Portfolio-in-China_FINAL-PR-NEWSWIRE.pdf

    PRESS RELEASE
    13 Jun 2024
    Share Share
    Ethypharm ready to bring to patients world-leading digital therapies
    Ethypharm ready to bring to patients world-leading digital therapies

    06 Apr 2024

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2022/10/Agreement-Gaia-AG-EN.pdf

    PRESS RELEASE
    06 Apr 2024
    Share Share
    Ethypharm announces the Appointment of Xavier LASSERRE as CCO
    Ethypharm announces the Appointment of Xavier LASSERRE as CCO

    13 Jun 2023

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2023/06/PR-Xavier-LASSERRE-appointed_CCO_Ethypharm-final.pdf

    PRESS RELEASE
    13 Jun 2023
    Share Share
    Aurora & Ethypharm Reaffirm their Commitment to Promote to Medical Cannabis
    Aurora & Ethypharm Reaffirm their Commitment to Promote to Medical Cannabis

    01 May 2023

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2023/05/Aurora_Ethypharm_Extension-Pilot-Program_FINAL-1.pdf

    PRESS RELEASE
    01 May 2023
    Share Share
    Bruno Ultra BARCELOS is appointed Managing Director of Ethypharm UK
    Bruno Ultra BARCELOS is appointed Managing Director of Ethypharm UK

    31 Jan 2023

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2023/01/Presse-release-_-Bruno-Ultra-BARCELOS-appointed-Managing-Director_Ethypharm-UK-_-EN.pdf

    PRESS RELEASE
    31 Jan 2023
    Share Share